| Financial Year |
March 31 2023 |
| Monetary Funds |
790,886,305.55 |
| Held-for-trading Financial Assets |
403,318,626.15 |
| Notes Receivable |
44,870,068.34 |
| Accounts Receivable |
1,303,791,096.24 |
| Advances to Suppliers |
35,356,994.34 |
| Other Receivables |
19,683,136.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
366,122,379.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
215,418,371.75 |
| Total Current Assets |
3,277,592,759.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,189,633.44 |
| Investment Properties |
-- |
| Fixed Assetes |
1,627,124,850.32 |
| Under-construction Projects |
1,252,266,229.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
93,007,923.74 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
23,778,150.70 |
| Deferred Income Tax Assets |
80,395,198.18 |
| Other Non-Current Assets |
56,405,159.26 |
| Sub-Total of Non-Current Assets |
3,164,719,588.72 |
| Total Assets |
6,442,312,348.69 |
| Short-Term Loans |
607,006,823.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
804,153,819.18 |
| Accounts Payable |
1,953,784,701.90 |
| Accounts Received In Advance |
20,000.00 |
| Employee Compensation Payable |
44,146,715.20 |
| Taxes Payable |
14,044,570.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,989,491.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
102,501,873.31 |
| Other Current Liabilities |
18,717,981.84 |
| Sub-Total of Current Liabilities |
3,567,373,673.30 |
| Long-term Loans |
252,444,400.00 |
| Bonds Payable |
11,700,000.00 |
| Long-Term Accounts Payable |
103,716,344.71 |
| Special Payable |
-- |
| Estimatied Liabilities |
644,336.78 |
| Deferred Income Tax Liabilities |
13,188,921.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
517,972,039.87 |
| Total Liabilities |
4,085,345,713.17 |
| Paid-In Capital(Or Share Stock) |
414,694,422.00 |
| Capital Surplus |
1,602,957,014.03 |
| Surplus Reserve |
14,370,587.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
297,968,824.98 |
| Minority Stockholder's Interest |
26,975,787.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,329,990,848.44 |
| Owner's Equity（Stockholder's Equity） |
2,356,966,635.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,442,312,348.69 |
